Regorafenib dose optimization study (ReDOS): Randomized phase II trial to evaluate dosing strategies for regorafenib in refractory metastatic colorectal cancer (mCRC): An ACCRU Network study Meeting Abstract


Authors: Bekaii-Saab, T. S.; Ou, F. S.; Anderson, D. M.; Ahn, D. H.; Boland, P. M.; Ciombor, K. K.; Jacobs, N. L.; Desnoyers, R. J.; Cleary, J. M.; Meyers, J. P.; Chiorean, E. G.; Pedersen, K.; Barzi, A.; Sloan, J.; McCune, J. S.; Lacouture, M. E.; Lenz, H. J.; Grothey, A.
Abstract Title: Regorafenib dose optimization study (ReDOS): Randomized phase II trial to evaluate dosing strategies for regorafenib in refractory metastatic colorectal cancer (mCRC): An ACCRU Network study
Meeting Title: 2018 Gastrointestinal Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 4 Suppl.
Meeting Dates: 2018 Jan 18-20
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-02-01
Language: English
ACCESSION: WOS:000436174100587
PROVIDER: wos
DOI: 10.1200/JCO.2018.36.4_suppl.611
Notes: Meeting Abstract: 611 -- Source: Wos
Altmetric Score
MSK Authors
  1. Mario E Lacouture
    248 Lacouture